Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuva...
Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis
About this item
Full title
Author / Creator
Publisher
Oxford: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
The safety, immunogenecity, and efficacy of two doses of an autoclaved-killed, whole cell
Leishmania amazonensis vaccine (IFLA/BR/67/PH8) and BCG adjuvant (
n=750) against cutaneous leishmaniasis (CL) was compared with placebo (
n=756) in a randomized, placebo-controlled, blinded study. Systemic and local side-effects were more frequent in...
Alternative Titles
Full title
Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71708895
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71708895
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2003.06.002
